It has been extensively demonstrated that adiponectin induces an anti-proliferative response in human estrogen receptor alpha (ERα)-negative breast cancer cells (8–10), while controversial data are reported in ERα-positive cells (11–16). The gene discussed is ADIPOQ; the disease is breast cancer.